| Title | Efficacy of Licartin and TACE for Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection |
| Abstract | Objective: To observe the effect of Licartin and TACE in the treatment of primary liver cancer recurrence.Methods: A total of 36 patients with hepatocellular carcinoma, who underwent radical resection from July 2009 to May 2010 in The First Affiliated Hospital of Fujian Medical University, were randomly divided into two groups: Licartin treatment group(study group) and TACE treatment group(control group), compared the toxicity and disease-free survival.Results: In study group, the incidence ofâ… /â…¡fever/chills was lower than the control group (P=0.027); the incidence of nausea/vomiting and pain was also lower than the control group, but not statistically significant (P>0.05). Patients in both groups appear thrombocytopenia, in which TACE treatment group decreased 21.8% (P = 0.000), Licartin treatment group decreased 11.5% (P = 0.012) . After the TACE treatment, the average of TBIL increase 29.1% (P=0.016), the average of ALB decrease 7.7% (P=0.010),the average of AST decrease 6.4% (P=0.472); After the Licartin treatment, the average of TBIL increase 11.6% (P=0.396), the average of ALB decrease 5.8% (P=0.112),the average of AST decrease 23.5% (P=0.414), no significant liver toxicity was observed in Licartin treatment group. The study group’s recurrence rate in 0.5 , 1 year and the total follow-up period were all lower than control group, but not statistically significant (P>0.05). The average tumor-free survival (14.962 months) longer than the TACE group (13.369 months), but not statistically significant ( P = 0.329).Conclusion: The effect of Licartin in the prevention of liver cancer recurrence after surgery is better than TACE, it is an ideal method of treatment with no significant liver toxicity. |
| Category | Oncology |
| Keywords | hepatocellular carcinoma, Licartin, recurrence, transcatheter arterial chemoembolization, |
| FileType | |
| Pages | 136 |
| Price | US$70.00 |
| Buy Now |
Buy This Research Paper Now! |
| Download | |
| Donation |
Donated for this research subject |
| Contact |
E-Mail:medpaper@hotmail.com TEL:1-888-786-998A |
| FAQ |
How to get this paper's electronic documents? 1, Click the "Buy Now" button to complete the online payment 2, Download the paper's electronic document from the successful payment return page/Or the system will send this paper's electronic document to your E-Mail within 24 hours |
| Favorite | ADD TO FAVORITE |
| Version | zh-cn |
Perhaps You will be interested in these papers
2013-01-08 Induction of Pluripotent Stem Cells from Hepatocellular Carcinoma Cell Lines
2013-01-08 Correlation and Significance of ADM and EPOR Expression in Hepatocellular Carcinoma
2013-01-08 Evaluation of HCC by Combined Detection of Serum AFP-IgM Complexes and Liver Function
Hello,My name is Jack,Ph.D. Supervisor, Welcome to My WebSite